Evidence map›Paper›PMID 27036650›Full record

ArticleBehavioural brain research2016

Nociceptin receptor antagonist SB 612111 decreases high fat diet binge eating.

J Andrew Hardaway, Jennifer Jensen, Michelle Kim, Christopher M Mazzone, Jonathan A Sugam, Jeffrey F Diberto, Emily G Lowery-Gionta, Lara S Hwa, Kristen E Pleil, Cynthia M Bulik and 1 more

Open access · greenAbstract read
In one paragraph

Article in Behavioural brain research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Sex Differences in Demand for Highly Palatable Foods: Role of the Orexin System.The international journal of neuropsychopharmacology · 2021
    Article
  14. Article
  15. Review
  16. Article
  17. PNOCNeuron · 2020
    Article
  18. NOP Receptor Antagonists Decrease Alcohol Drinking in the Dark in C57BL/6J Mice.Alcoholism, clinical and experimental research · 2019
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

J Andrew HardawayBowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, NC, USA; UNC Department of Pharmacology, University of North Carolina at Chapel Hill, NC, USA.
Jennifer JensenBowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, NC, USA; UNC Department of Pharmacology, University of North Carolina at Chapel Hill, NC, USA.
Michelle KimBowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, NC, USA; UNC Department of Pharmacology, University of North Carolina at Chapel Hill, NC, USA.
Christopher M MazzoneBowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, NC, USA; UNC Department of Pharmacology, University of North Carolina at Chapel Hill, NC, USA.
Jonathan A SugamBowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, NC, USA; UNC Department of Pharmacology, University of North Carolina at Chapel Hill, NC, USA.
Jeffrey F DibertoBowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, NC, USA; UNC Department of Pharmacology, University of North Carolina at Chapel Hill, NC, USA.
Emily G Lowery-GiontaBowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, NC, USA; UNC Department of Pharmacology, University of North Carolina at Chapel Hill, NC, USA.
Lara S HwaBowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, NC, USA; UNC Department of Pharmacology, University of North Carolina at Chapel Hill, NC, USA.
Kristen E PleilBowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, NC, USA; UNC Department of Pharmacology, University of North Carolina at Chapel Hill, NC, USA.
Cynthia M BulikUNC Department of Psychiatry, University of North Carolina at Chapel Hill, NC, USA; UNC Department of Nutrition, University of North Carolina at Chapel Hill, NC, USA; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Thomas L KashBowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, NC, USA; UNC Department of Pharmacology, University of North Carolina at Chapel Hill, NC, USA. Electronic address: thomas_kash@med.unc.edu.
University of North Carolina at Chapel Hill · USKarolinska Institutet · SE

Funding

UNC ARC Information/Dissemination CoreP60AA011605 · NIAAA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Thomas L. Kash · 2003 to 2026
$46.3M
UNIV OF NORTH CAROLINA CLINICAL NUTRITION RESEARCH UNITP30DK056350 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Ian Michael Carroll · 1999 to 2026
$31.6M
Probing Ethanol Induced Acceleration of Hindbrain and Amygdalar Pathology in an Alzheimer’s Disease ModelU01AA020911 · NIAAA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Thomas L. Kash, Zoe Anastasia McElligott · 2012 to 2026
$5.8M
The Role of Serotonin in Alcohol-Withdrawal Induced AnxietyR01AA019454 · NIAAA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Thomas L. Kash · 2010 to 2026
$5.6M
MOLECULAR AND CELLULAR PATHOGENESIS IN ALCOHOLISMP50AA011605 · NIAAA · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI CREWS, FULTON T · 1998 to 2002
$4.9M
DREADD2.0: AN ENHANCED CHEMOGENETIC TOOLKITU01MH105892 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JIN, JIAN, KASH, THOMAS L. · 2014 to 2016
$3.0M
Postdoctoral Research Training in Eating DisordersT32MH076694 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BULIK, CYNTHIA M · 2007 to 2016
$1.8M
Presynaptic Mechanisms Regulating the Dopamine TransporterF31MH093102 · NIMH · VANDERBILT UNIVERSITY · PI HARDAWAY, JAMES ANDREW · 2010 to 2013
$75k
Alcohol Modulation of a Novel Local BNST CircuitF31AA023440 · NIAAA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MAZZONE, CHRISTOPHER · 2015 to 2016
$60k
NIAAA NIH HHS F31 AA023440NIAAA NIH HHS P50 AA011605NIAAA NIH HHS P60 AA011605NIAAA NIH HHS R01 AA019454NIAAA NIH HHS U01 AA020911NIDDK NIH HHS P30 DK056350NIMH NIH HHS F31 MH093102NIMH NIH HHS T32 MH076694NIMH NIH HHS U01 MH105892
6 · The paper itself

Abstract

Binge eating is a dysregulated form of feeding behavior that occurs in multiple eating disorders including binge-eating disorder, the most common eating disorder. Feeding is a complex behavioral program supported through the function of multiple brain regions and influenced by a diverse array of receptor signaling pathways. Previous studies have shown the overexpression of the opioid neuropeptide nociceptin (orphanin FQ, N/OFQ) can induce hyperphagia, but the role of endogenous nociceptin receptor (NOP) in naturally occurring palatability-induced hyperphagia is unknown. In this study we adapted a simple, replicable form of binge eating of high fat food (HFD). We found that male and female C57BL/6J mice provided with daily one-hour access sessions to HFD eat significantly more during this period than those provided with continuous 24h access. This form of feeding is rapid and entrained. Chronic intermittent HFD binge eating produced hyperactivity and increased light zone exploration in the open field and light-dark assays respectively. Treatment with the potent and selective NOP antagonist SB 612111 resulted in a significant dose-dependent reduction in binge intake in both male and female mice, and, unlike treatment with the serotonin selective reuptake inhibitor fluoxetine, produced no change in total 24-h food intake. SB 612111 treatment also significantly decreased non-binge-like acute HFD consumption in male mice. These data are consistent with the hypothesis that high fat binge eating is modulated by NOP signaling and that the NOP system may represent a promising novel receptor to explore for the treatment of binge eating.

Indexed as

Adaptation, OcularAnalysis of VarianceAnimalsAntidepressive Agents, Second-GenerationBulimiaCycloheptanesDiet, High-FatDisease Models, AnimalDose-Response Relationship, DrugExploratory BehaviorFemaleFluoxetineMaleMaze LearningMiceMice, Inbred C57BLAntidepressive Agents, Second-Generationcis-1-methyl-7-((4-(2,6-dichlorophenyl)piperidin-1-yl)methyl)-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-olCycloheptanesFluoxetineNociceptin ReceptorOprl1 protein, mousePiperidinesReceptors, OpioidBinge eatingFluoxetineHigh fatHyperphagiaIntermittent accessNociceptin

Identifiers

PMID27036650
PMCPMC4896639
OpenAlexW2326627869

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.